INVITATION TO ATTEND

The RNA Institute, in partnership with CCRM Australia and the NSW Stem Cell Network, is proud to present the The Business of Advanced Therapeutics Masterclass 2026 on 24 March 2026 at the UNSW Business School, Kensington. This flagship event brings together leading experts, industry innovators, and academic thought leaders to explore the future of advanced therapeutics and their impact on global healthcare.

Designed to provide a comprehensive grounding in cutting-edge therapeutic modalities—including RNA-based therapies, gene therapies, and cell and tissue engineering—the Masterclass offers insights into the scientific, regulatory, and commercial trends shaping the sector. Join us for a keynote address on global investment in life sciences infrastructure, a curated program of expert presentations and interactive sessions, and exceptional networking opportunities within Australia’s growing advanced therapies ecosystem.

0:00
0:00

ORGANISING COMMITTEE

Silvio Tiziani

Catherine McDonald

Andre Serobian

Brad Eberand

Margret Schuller

Marjorie Fox-Owens

Chihwei Teng

Rachel Shparberg

MEET THE

SPEAKERS

Leah Goodman

CEO, Biointelect

Dr John Ratcliffe

Chief Investment Officer, Altea Investments

Dr Peter Brown

Special Council, Griffith Hack

Silvio Tiziani

CEO, CCRM Australia

Malcolm Lyons

Principal, Griffith Hack

Brent McPherson

National Business Development Manager AUS & NZ, World Courier

Professor Anthony (Tony) Kelleher

Director of The Kirby Institute, UNSW

James Chong

Professor, Centre Director,

Westmead Hospital

Dr Robert Lin

CEO, GreenLight Clinical

Prof Michelle Farrar

Paediatric

Neurologist, Sydney Children's Hospital

And more to come...


WITH THANKS TO

FOR ENQUIRIES, CONTACT LEISHMAN ASSOCIATES

227 Collins Street, Hobart, TAS 7000

P: +61 3 6234 7844

E: conference@leishman-associates.com.au